Brief: Crinetics Pharmaceuticals Announces Proposed Public Offering Of Common Stock
05/01/2026 22:14
Crinetics Pharmaceuticals Inc CRNX.O: CRINETICS PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK CRINETICS PHARMACEUTICALS INC - TO OFFER $350 MILLION IN PUBLIC STOCK OFFERING CRINETICS PHARMACEUTICALS INC - UNDERWRITERS GRANTED 30-DAY OPTION FOR $52.5 MILLION ADDITIONAL SHARES CRINETICS PHARMACEUTICALS INC - PROCEEDS TO FUND PALSONIFY LAUNCH AND RESEARCH AND DEVELOPMENT Source text: ID:nGNX4gz8Y Further company coverage: CRNX.O
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million